Fredun Pharma Receives SEBI Adjudication Order: No Financial Penalty Imposed Jul 10, 2025
Fredun Pharmaceuticals Expands into Pet Care with One Pet Stop Acquisition Jun 30, 2025
More news about Fredun Pharmaceuticals
11Apr 25
Fredun Pharma Secures Major Tender from Tamil Nadu Medical Services Corporation
Fredun Pharma has secured a significant tender from the Tamil Nadu Medical Services Corporation (TNMSC) for supplying generic medicines. The contract, valued between Rs. 150.00 crore and Rs. 180.00 crore, is expected to boost the company's revenue, enhance its market position, and demonstrate its capability in meeting government tender requirements. This achievement marks Fredun Pharma's expansion in the government healthcare supply chain and could lead to increased production scale and potential opportunities in other states.
09Apr 25
Fredun Pharma Secures Rs. 150-180 Crore Tender from Tamil Nadu Medical Services Corporation
Fredun Pharmaceuticals Limited has been awarded a tender by the Tamil Nadu Medical Services Corporation (TNMSC) for supplying generic medicines. The tender, valued between Rs. 150-180 crore, will be executed over 14 months starting from Q1 FY26. The medicines will be supplied under the company's 'Fredun Gx' brand. This development is expected to significantly boost Fredun Pharma's revenue and strengthen its position in the public health sector.
18Mar 25
Fredun Pharma's Freossi Division Makes International Debut in Sri Lanka
Fredun Pharmaceuticals Limited's pet care division, Freossi, has launched nine premium pet care products in Sri Lanka, marking its first international expansion. The product range includes MCHC, functional, therapeutic, and grooming lines. Over 20 additional products are under review by Sri Lankan regulators. The launch event was inaugurated by Prof. Ashoka Dangolla and received positive feedback from industry experts. Managing Director Fredun Medhora expressed enthusiasm about the expansion and its potential impact on pet welfare in Sri Lanka.
12Mar 25
Fredun Pharmaceuticals Expands Veterinary Portfolio with Large Animal Healthcare Products
Fredun Pharmaceuticals Limited has announced its entry into the large animal healthcare segment with the launch of two new products under the FREOSSI Large Animals brand. The company introduced Freossi Tone+, a lactation solution for large animals, and Freossi Power, focused on strength and mobility for livestock. Both products are formulated with Microcrystalline Hydroxyapatite Complex (MCHC) and other scientifically backed ingredients. This strategic expansion builds on the company's success in companion animal care and aims to strengthen its position in the animal health industry. The move is part of a broader strategy to expand Fredun Pharma's footprint in veterinary healthcare.
11Mar 25
Fredun Pharmaceuticals Expands Veterinary Portfolio with Large Animal Products
Fredun Pharmaceuticals Limited has announced its entry into the large animal products segment, expanding its veterinary healthcare business. The company is launching two new products under the FREOSSI Large Animals brand: Freossi Tone+, a lactation solution, and Freossi Power, a supplement for strength and mobility in livestock. Freossi Tone+ aims to improve milk yield, quality, and lactation cycles in large animals, while Freossi Power targets joint issues and mobility in horses, bulls, ponies, and cattle. This strategic move diversifies Fredun Pharma's product portfolio and strengthens its presence in the animal health sector.